Sutro Biopharma, Inc.
Sutro Biopharma, Inc. (STRO) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001382101 · STRO · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001382101 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Sutro Biopharma, Inc. (NASDAQ: STRO) has submitted 610 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001382101, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Sutro Biopharma, Inc.'s most comprehensive regulatory disclosure. The most recent Sutro Biopharma, Inc. 10-K was filed on 2026-03-23 for fiscal year ending 2026. Historical STRO 10-K annual reports are available from 2006 through 2026.
Investors researching Sutro Biopharma, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
STRO SEC Filings · 8 questionsSutro Biopharma, Inc. (STRO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 610 filings and access original documents at no cost. Sutro Biopharma, Inc.'s CIK is 0001382101.